Site Search
Displaying results 281 - 290 of 573
Key Changes Made in the Lives of People who Use Drugs in China, Kenya, India, Indonesia and Malaysia
Resource | Publications,
Community Action on Harm Reduction (CAHR) is an ambitious programme implemented between 2011 and 2015 with the objective of expanding coverage of HIV prevention, treatment and care, sexual and reproductive health and other services to more than 230,000 people who inject drugs (PWID), their partners and children in five countries – China, India, Indonesia, Kenya and Malaysia – and, since 2015, with the addition of Myanmar, through funding from the Social Department/Health and AIDS Division of the Ministry of Foreign Affairs of the Government of The Netherlands. Due to specific higher-risk behaviours, PWID are at increased risk of HIV irrespective of the epidemic type or local context; they often have legal and social issues related to their behaviours that increase their vulnerability to HIV.
This briefing document highlights the impact on the lives of PWID and their family members of the CAHR programme as well as the continued support needed by PWID to fully realise their right to quality health services that are evidence-based and free from stigma and discrimination.
Resource | Publications,
The aim of the new initiative is to leverage improved, accessible, affordable and optimally used diagnostic technologies and strategies to ensure achievement of a bold new HIV treatment target for 2020.
Resource | Publications,
Launched only a year ago, Fast-Track cities has rapidly taken root and grown. This is the first annual update on progress in implementing the Fast-Track cities approach and it supports one of the seven key commitments contained in the Paris Declaration. This report reflects on the actions taken by cities and by the four core partners— the city of Paris, UNAIDS, the United Nations Human Settlements Programme (UN-Habitat) and the International Association of Providers of AIDS Care (IAPAC)—towards ending the AIDS epidemic as a public health threat by 2030. Future reports will illustrate good practices and quantifiable evidence of progress that will inspire and inform Fast-Track cities and the many stakeholders helping to confront AIDS as a health and development challenge.
Resource | Guidelines,
To minimize the emergence and spread of HIV drug resistance (HIVDR), the World Health Organization recommends HIV treatment scale-up be accompanied by measures to monitor and improve the quality of ART delivery and surveillance of HIVDR.
This update provides an overview of the essential elements that programme managers should include in programme planning to prevent and monitor the emergence of HIVDR. It also describes programmatic relevance and use of data.
Resource | Publications,
HIV treatment is a cornerstone of the AIDS response, helping to prevent AIDS-related deaths and avert new infections. It also helps people living with HIV to live close-to-normal lifespans, thereby reducing HIV-related stigma. Evidence shows that HIV treatment, administered ideally as soon as possible after diagnosis, not only slows disease progression but also prevents onward HIV transmission. Moreover, the right to the highest attainable standard of health necessitates access to treatment and other medicines to ensure that people living with HIV can have long and productive lives.
Resource | Data Sheets,
Surveillance of transmitted HIV drug resistance (TDR) in individuals recently infected with HIV was performed following WHO-suggested methods. The prevalence of transmitted HIV drug resistance (TDR) in recently infected antiretroviral drug naïve individuals in PNG has not been fully characterised.
Resource | Publications,
The development of AIDS Epidemic Model for Ending AIDS in Malaysia marks another important milestone in the country’s unswerving commitment in shaping effective and sustainable response to the epidemic. To date, the country has notched many successes through its determined leadership aimed at reversing and halting the epidemic. New HIV infection rate has declined by half, falling from 22 per 100,000 populations in 2000 to 11 per 100,000 populations in 2009. The number of new infections have been stable in the past five years though it edged up in 2010.
Our almost three-decade long response to the HIV epidemic without signs of complacency has enabled us to achieve the MDG 6 target of reducing by half the proportion of new HIV infections. We need to build on these successes and maintain the momentum. The challenge is to sustain the achievement and embark on the fast track strategy to close the book on AIDS epidemic by 2030 or earlier, the first effort of its kind in the country. To achieve this goal, a powerful yet realistic tool such as the AIDS Epidemic Model (AEM) is pivotal.
Resource | Publications,
Hundreds of millions of people are affected by humanitarian emergencies each year. Of the 314 million people affected by humanitarian emergencies in 2013, 1.6 million were people living with HIV. Of these, 1.3 million people (81%) were in sub-Saharan Africa. Many were displaced, lacked access to essential HIV services and suffered as a result of shortages that could have been avoided.
1 million people living with HIV did not access treatment in humanitarian emergencies in 2013. When 1.6 million people living with HIV were affected by humanitarian emergencies in 2013, they suffered service disruptions and restrictive policies that threatened their lives. More than one million people were estimated to have been unable to access anti-retroviral therapy, due to humanitarian emergencies.
Resource | Publications,
In this issue brief we first review trends in generic competition and intellectual property (IP) licensing for key antiretroviral drugs. We then outline seven momentous decisions to be made in 2015 that will largely determine whether ART will be affordable, available and robust for the next 15 years of treatment scale-up to all people living with HIV. This includes opportunities for greatly improved treatment regimens based on WHO guidelines on when to start treatment, and what first- and second line regimens should include.
Resource | Publications,
In 2012, the Treatment 2015 initiative was launched, which aimed to redouble efforts to achieve the global target of reaching 15 million people with HIV treatment by 2015. Determined to achieve a highly ambitious global treatment target by the agreed deadline, UNAIDS called for concerted global action to increase the speed of HIV treatment scale-up, enhance the programmatic focus on those most in need, and foster innovation in HIV testing and treatment approaches.
Emerging three years after the launch of Treatment 2015, this report celebrates the world's achievement of this historic milestone, which is saving more lives than ever before. As this report reveals, we have indeed learned how to do better in bringing HIV treatment to those who need it.